Single-cell Biotech
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- $28M
Investors
- 5
About Single-cell Biotech
, trading as Single-cell Biotech, operates as a biotechnology company that focuses on single-cell analyzers and supporting reagent consumables R&D. Xu Jian, co-founder of the company, is currently the director of the Bioenergy Research Office and the Single Cell Center of the Qingdao Institute of Energy, Chinese Academy of Sciences. The company provides metabolic phenome based single-cell imaging, sorting, sequencing, and culture solutions for many fields, such as precision medicine, human and environmental micro-ecology, bioresource mining. The business of the company includes the development and commercialization of novel single-cell medical and scientific instruments. The company's products include instruments, kits & chips, and software. Instruments include CAST-R, FlowRACS, EasySort Lego and RACS-Seq. The software includes RamEX, RamDB, and RamLIS. Kits & chips include sampling for cell analysis, SCRS acquisition and Raman-activated cell sorting. The company generates revenue by selling single-cell analytical instruments and supporting reagents and consumables include high-throughput flow Raman sorter FlowRACS, clinical single-cell Raman drug sensitivity fast test CAST-R, single-cell Raman light tweezer's sorter RACS-Seq.
Who invested in Single-cell Biotech
5 investors across 2 rounds
See all investors in Single-cell Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Single-cell Biotech
Who invested in Single-cell Biotech?
Single-cell Biotech has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Single-cell Biotech raised?
Single-cell Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Single-cell Biotech last raise money?
Single-cell Biotech's most recent round on record is a Series A, in Jan 2026.
What does Single-cell Biotech do?
, trading as Single-cell Biotech, operates as a biotechnology company that focuses on single-cell analyzers and supporting reagent consumables R&D.
Where is Single-cell Biotech headquartered?
Single-cell Biotech is headquartered in Qingdao, China.
Which VCs invest in companies like Single-cell Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Single-cell Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Single-cell Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.